Browse the full insider trade history of NYMOX PHARMACEUTICAL CORP, a listed issuer based in United States. Shares are listed on US US, under the supervision of SEC (Form 4). Market capitalisation: €7.6m. The latest transaction was disclosed on 26 June 2023 (Acquisition). Among the most active insiders: Robinson James George. All data is accessible without an account.
15
Insider Decl.
0
Thresholds
€32,792
15 ops.
Buy Volume
·
0 ops.
Sell Volume
20Σ signal
Buys €32,792· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.